{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:45:08Z","timestamp":1757630708172,"version":"3.44.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.gassur.2025.102187","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T06:47:38Z","timestamp":1755067658000},"page":"102187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel scoring system for prognostic stratification of node-positive pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5201-4477","authenticated-orcid":false,"given":"Yoichi","family":"Miyata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keigo","family":"Tani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Einama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Togashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10041","key":"10.1016\/j.gassur.2025.102187_bib1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0140-6736(16)30583-9","article-title":"Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)","volume":"388","author":"Uesaka","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.gassur.2025.102187_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jhbp.844","article-title":"Neoadjuvant gemcitabine and nab-paclitaxel for borderline resectable pancreatic cancers: intention-to-treat analysis compared with upfront surgery","volume":"28","author":"Inoue","year":"2021","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"14","key":"10.1016\/j.gassur.2025.102187_bib3","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2013.279201","article-title":"Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial","volume":"310","author":"Oettle","year":"2013","journal-title":"JAMA"},{"issue":"10073","key":"10.1016\/j.gassur.2025.102187_bib4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(16)32409-6","article-title":"Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial","volume":"389","author":"Neoptolemos","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.gassur.2025.102187_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/SLA.0000000000002705","article-title":"Oncological benefits of neoadjuvant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: a prospective, randomized, open-label, multicenter Phase 2\/3 trial","volume":"268","author":"Jang","year":"2018","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.gassur.2025.102187_bib6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.surg.2014.02.001","article-title":"Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)","volume":"155","author":"Bockhorn","year":"2014","journal-title":"Surgery"},{"issue":"8","key":"10.1016\/j.gassur.2025.102187_bib7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1245\/ASO.2006.08.011","article-title":"Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy","volume":"13","author":"Varadhachary","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.gassur.2025.102187_bib8","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1245\/s10434-009-0413-9","article-title":"Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement","volume":"16","author":"Abrams","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.gassur.2025.102187_bib9","unstructured":"National Comprehensive Cancer Network. NCCN practice guidelines for pancreatic cancer. version 2.2025; https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/pancreatic.pdf; August 29, 2025."},{"issue":"4","key":"10.1016\/j.gassur.2025.102187_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10147-023-02317-x","article-title":"Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis","volume":"28","author":"Okusaka","year":"2023","journal-title":"Int J Clin Oncol"},{"year":"2017","series-title":"TNM classification of malignant TumorsTNM classification of malignant tumors","author":"International Union Against Cancer (UICC)","key":"10.1016\/j.gassur.2025.102187_bib11"},{"key":"10.1016\/j.gassur.2025.102187_bib12","unstructured":"Kanehara & Co., Ltd. Classification of pancreatic carcinoma. 4th English ed. Japan Pancreas Society; 2017."},{"issue":"2","key":"10.1016\/j.gassur.2025.102187_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/jjco\/hyy190","article-title":"Randomized phase II\/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02\/JSAP05)","volume":"49","author":"Motoi","year":"2019","journal-title":"Jpn J Clin Oncol"},{"issue":"18","key":"10.1016\/j.gassur.2025.102187_bib14","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.gassur.2025.102187_bib15","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gassur.2025.102187_bib16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1186\/s12885-018-4901-9","article-title":"Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis","volume":"18","author":"Li","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.gassur.2025.102187_bib17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/SLA.0000000000001837","article-title":"Does size matter in pancreatic cancer?: reappraisal of tumour dimension as a predictor of outcome beyond the TNM","volume":"266","author":"Marchegiani","year":"2017","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.gassur.2025.102187_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/SLA.0000000000001763","article-title":"Multi-institutional validation study of the American Joint Commission on Cancer (8th edition) changes for T and N staging in patients with pancreatic adenocarcinoma","volume":"265","author":"Allen","year":"2017","journal-title":"Ann Surg"},{"issue":"13","key":"10.1016\/j.gassur.2025.102187_bib19","doi-asserted-by":"crossref","first-page":"8621","DOI":"10.1245\/s10434-023-14219-3","article-title":"Impact of preoperative tumor size on prognosis of resectable and borderline resectable pancreatic ductal adenocarcinomas","volume":"30","author":"Miyata","year":"2023","journal-title":"Ann Surg Oncol"},{"year":"2019","series-title":"Japanese classification of colorectal, appendiceal, and anal carcinoma","author":"Masahumi Inomata","key":"10.1016\/j.gassur.2025.102187_bib20"},{"issue":"7","key":"10.1016\/j.gassur.2025.102187_bib21","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1245\/s10434-019-07390-z","article-title":"A single-institution validation study of lymph node staging by the AJCC 8th edition for patients with pancreatic head cancer: a proposal to subdivide the N2 category","volume":"26","author":"Asano","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.gassur.2025.102187_bib22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/SLA.0000000000000814","article-title":"Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories","volume":"261","author":"Strobel","year":"2015","journal-title":"Ann Surg"},{"issue":"35","key":"10.1016\/j.gassur.2025.102187_bib23","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.3748\/wjg.v27.i35.5851","article-title":"Pancreatic cancer in 2021: what you need to know to win","volume":"27","author":"Tonini","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gassur.2025.102187_bib24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.surg.2019.12.008","article-title":"Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomy","volume":"167","author":"Maeda","year":"2020","journal-title":"Surgery"},{"issue":"9","key":"10.1016\/j.gassur.2025.102187_bib25","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s11605-020-04870-6","article-title":"Impact of resection margin status in patients with pancreatic cancer: a national cohort study","volume":"25","author":"Kaltenmeier","year":"2021","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.gassur.2025.102187_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","article-title":"Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis","volume":"10","author":"Mazzaferro","year":"2009","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.gassur.2025.102187_bib27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/jso.24678","article-title":"The prognostic utility of the \u201ctumor burden Score\u201d based on preoperative radiographic features of colorectal liver metastases","volume":"116","author":"Sasaki","year":"2017","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2025.102187_bib28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/SLA.0000000000002064","article-title":"The tumor burden score: a new \u201cmetro-ticket\u201d prognostic tool for colorectal liver metastases based on tumor size and number of tumors","volume":"267","author":"Sasaki","year":"2018","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.gassur.2025.102187_bib29","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1245\/s10434-025-16917-6","article-title":"Dissecting tumor size underestimation in pancreatic cancer: a comparative analysis of preoperative treatments","volume":"32","author":"Kobayashi","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.gassur.2025.102187_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.suronc.2014.10.005","article-title":"Diagnostic accuracy of CT in assessing extra-regional lymphadenopathy in pancreatic and peri-ampullary cancer: a systematic review and meta-analysis","volume":"23","author":"Tseng","year":"2014","journal-title":"Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2025.102187_bib31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1148\/radiol.220329","article-title":"Artificial intelligence to predict lymph node metastasis at CT in pancreatic ductal adenocarcinoma","volume":"306","author":"Bian","year":"2023","journal-title":"Radiology"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X2500246X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X2500246X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T19:16:52Z","timestamp":1757531812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X2500246X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1091255X2500246X"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2025.102187","relation":{},"ISSN":["1091-255X"],"issn-type":[{"type":"print","value":"1091-255X"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel scoring system for prognostic stratification of node-positive pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2025.102187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102187"}}